Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20092
20212
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing University School of Medicine2
Bio-Thera Solutions1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Everest Medicines (China) Co.,Ltd.1
George (Beijing) Clinical Research Co. Ltd.1
Hansoh BioMedical R&D Company1
Hospital Authority, Hong Kong1
Sanofi1
Xi'an Jiaotong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental12
Glomerulonephritis, IGA4
Nephrosis, Lipoid4
Glomerulonephritis, Membranous3
Diabetic Nephropathies2
Kidney Diseases2
Glomerulonephritis1
Proteinuria1
Renal Insufficiency, Chronic1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.